Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
NT-I7, a Long-Acting Interleukin 7, Increases Lymphocyte Counts and Induces CD8+ T-cell Clonotype Expansion in Patients with Newly Diagnosed High-Grade Gliomas.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 06, 2025
Phase I study of NT-I7, a long-acting interleukin-7, in severe treatment-related lymphopenia following standard radiation and temozolomide for high-grade glioma.
Journal: Neuro-oncology advances
Published: July 24, 2025
Expansion and mobilization of virus-specific stem-like CD8 T cells in chronic viral infection after treatment with a long-acting IL-7, NT-I7.
Journal: Cell reports
Published: October 09, 2024
rhIL-7-hyFc, a long-acting interleukin-7, improves efficacy of CAR-T cell therapy in solid tumors.
Journal: Journal for immunotherapy of cancer
Published: July 10, 2024
Targeting ROS-sensing Nrf2 potentiates anti-tumor immunity of intratumoral CD8+ T and CAR-T cells.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 26, 2024
An "off-the-shelf" CD2 universal CAR-T therapy for T-cell malignancies.
Journal: Leukemia
Published: June 26, 2023
Anti-myeloma efficacy of CAR-iNKT is enhanced with a long-acting IL-7, rhIL-7-hyFc.
Journal: Blood advances
Published: February 21, 2023
The Role of Interleukin-7 in the Formation of Tertiary Lymphoid Structures and Their Prognostic Value in Gastrointestinal Cancers.
Journal: Journal of immunotherapy and precision oncology
Published: May 19, 2022
Advancements of Common Gamma-Chain Family Cytokines in Cancer Immunotherapy.
Journal: Immune network
Published: January 03, 2022
Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer.
Journal: Breast cancer research and treatment
Published: May 25, 2021
Last Updated: 09/26/2026